Apollomics APLM
NASDAQ APLM
$18.60 +0.35 (+1.92%)
As of: Nov 10, 2026 · 1:27 PM EST

Apollomics (APLM) Current Assets (2021 - 2025)

Updated

Apollomics' Current Assets came in at $6.05 million for Q4 2025, down 41.1% from $10.27 million a year earlier.

Analysis

Apollomics (APLM) Current Assets (2021 - 2025) Analysis & Trends

Going back to Q4 2021, Apollomics' Current Assets data covers 8 quarters.

  • Current Assets has declined in each of the last four years, with a four-year compound annual growth rate of -50.3% (FY2021 to FY2025).
  • Going back by year, Current Assets was $10.27 million in FY2024 (-74.3%), $39.93 million in FY2023 (-28.4%), $55.79 million in FY2022 (-43.9%) and $99.37 million in FY2021.
  • The Q4 2025 figure represents the lowest quarterly Current Assets in data going back to Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 65.26 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 56.35 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 37.48 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 38.94 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 27.35 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 27.97 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 34.36 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 16.55 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 45.01 Bn
10 Apollomics 40.08 Mn -1.02 Mn - 6.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 6.05 Mn
Jun 30, 2025 10.13 Mn
Dec 31, 2024 10.27 Mn
Jun 30, 2024 28.41 Mn
Dec 31, 2023 39.93 Mn
Jun 30, 2023 55.38 Mn
Dec 31, 2022 55.79 Mn
Dec 31, 2021 99.37 Mn
API Access

Apollomics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=APLM&period=max&api_key=YOUR_API_KEY